Thomas Kassberg
2014
In 2014, Thomas Kassberg earned a total compensation of $491.9K as Senior Vice President and Chief Business Officer at Ultragenyx Pharmaceutical, a 19% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $112,219 |
---|---|
Salary | $362,857 |
Other | $16,863 |
Total | $491,939 |
Kassberg received $362.9K in salary, accounting for 74% of the total pay in 2014.
Kassberg also received $112.2K in non-equity incentive plan and $16.9K in other compensation.
Rankings
In 2014, Thomas Kassberg's compensation ranked 10,314th out of 13,032 executives tracked by ExecPay. In other words, Kassberg earned more than 20.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,314 out of 13,032 | 21st |
Division Manufacturing | 3,918 out of 4,966 | 21st |
Major group Chemicals And Allied Products | 1,343 out of 1,686 | 20th |
Industry group Drugs | 1,074 out of 1,365 | 21st |
Industry Pharmaceutical Preparations | 825 out of 1,043 | 21st |
Source: SEC filing on April 28, 2015.
Kassberg's colleagues
We found three more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2014.